baber/WOPTO huggingface dataset:
Patent CA-2488161-A1 (CA)
Inventor: EIKI JUNICHI
IPC: A61K31/437
Filed: 2003-03-25
Abstract: L'invention concerne un composé ou un sel pharmaceutiquement acceptable de formule (I), dans laquelle R¿1? est -S(O)¿p?-A, -S-(O)¿q?-B, ou -O-D (p et q valant indépendamment entre 0 et 2; A étant alkyle C¿1-10? linéaire éventuellement substitué; B et D étant chacun indépendamment c une structure cyclique substituée); R¿2? est hydrogène, etc.; X¿1? et X¿2? sont chacun indépendamment azote ou CH, à condition que les deux ne soient pas azote; et la structure présente un groupe hétéroayle monocyclique ou bicyclique contenant de l'azote, adjacent à l'atome de carbone lié au groupe amide. Le composé considéré à une activité glucokinase, et il est utile pour le traitement du diabète, de la néphropathie diabétique, de la rétinopathie diabétique, de la neuropathie diabétique, de l'artériosclérose diabétique, etc.
Patent CA-2489339-A1 (CA)
Title: Shaped anti-roll supports and garments incorporating such supports
Inventor: WEINERTH PETER
IPC: A41C5/00
Filed: 2003-06-10
Abstract: A shaped support for a body-shaping garment, including a foundation garment, such as a brassiere or girdle, is formed from a single or from multiple laye rs of a plastic material having certain flex modulus and perpendicular and in- plane apparent stiffnesses, such as a polyester film with a thickness in the range of from15 to 35 mil. The shaped support is incorporated into the structure of the body-shaping garment, preferably by adhering the support directly to the fabric comprising the body-shaping garment using a film or h ot melt adhesive. The shaped support preferably has an asymmetric shape and readily conforms to various body curvatures for increased wearing comfort, b ut has sufficient stiffness to provide desired lifting or holding support.</SDO AB>
Patent CA-2491321-A1 (CA)
Inventor: GERMANI ANTONIA
IPC: A61K38/00
Filed: 2003-04-29
Abstract: It is described a composition comprising an effective amount of the HMGB1 protein or functional parts thereof, or HMGB1 expressing vectors, for the treatment of tissue damage and/or to promote tissue repair and regeneration.  It is further described a composition comprising an effective amount of an antagonist of the HMGB1 protein for the treatment of adverse effects induced by necrotic tissue, such as recruitment and activation of myeloid cells, loss of the barrier function of endothelia, edema.
Patent CA-2491998-A1 (CA)
Title: Azabicyclo derivatives as muscarinic receptor antagonists
Inventor: SILAMKOTI ARUNDUTT VISWANATHAM
IPC: A61P1/14
Filed: 2003-04-11
Abstract: This invention generally relates to muscarinic receptor antagonists which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. Specifically, the invention relates to derivatives of azabicyclo compounds, including, for example, 6-substituted azabicyclo[3.1.0] hexanes, and 2,4,6-trisubstituted derivatives. The invention also relates to pharmaceutical compositions containing the compounds and the methods of treating the diseases mediated through muscarinic receptors.
Patent CA-2496115-A1 (CA)
Inventor: KIM HUN S
IPC: E02B3/12
Filed: 2005-02-08
Abstract: The invention provides a sandbag having a waist portion. The waist has a smaller cross-sectional area than the remainder of the bag, forming a bag shape that has greater resistance to movement when embedded in the backfill material supported by a sandbag wall. In use, the sandbags with a waist portion are positioned so as to extend from the wall face into the backfill, thus stabilizing the wall.
Patent CA-2497623-A1 (CA)
Inventor: BAUMGARTNER DANIEL
IPC: A61F2/00
Filed: 2002-09-18
Abstract: L'invention concerne un implant, en particulier un implant d'articulation intervertébrale, comprenant A) deux éléments d'articulation (4 ; 5) présentant respectivement un axe central (1 ; 26), une surface de glissement (6 ; 7) courbe coupant l'axe central (1 ; 26) et une extrémité (14 ; 15) située axialement à l'extérieur et pouvant être reliée à un os, B) les surfaces de glissement (6 ; 7) présentant une forme courbe et pouvant coulisser l'une sur l'autre et D) le second élément d'articulation (5) pouvant être mis en rotation par rapport au premier élément d'articulation (4) autour de deux axes de rotation (10 ; 11).
Patent CA-2500910-A1 (CA)
Title: Resin deck board with water drainage top surface
Inventor: SHOWERS JOHN
IPC: E04B5/00
Filed: 2005-03-15
Abstract: A resin deck board has a top surface with a plurality of water drainage channels spaced from one another extending axially in the top surface of the board. The top surface of the board also includes a plurality of feed channels which are angled relative to and which intersect with the drainage channels. The drainage channels penetrate to a depth at least as great as that of the feed channels into the top surface of the board to promote water from the feed channels to drain in to the drainage channels which then carry the water off of the top surface of the deck.
Patent CA-2505363-A1 (CA)
Title: Process and device for separating oil and volatile organic components from pressurized gases of a compression system
Inventor: BAUER HEINZ
IPC: B01D45/06
Filed: 2005-04-27
Abstract: A process and device for separating oil and volatile organic components from pressurized gases of a compression system in which, before oxidation-catalytic separation, a physical separation is performed to protect the oxidation-catalytic separator against a large amount of oil being entrained in a surge in the pressurized gases. The resulting oil which has been separated in this physical oil separation is then fed back into the pressurized gas flow which is flowing to oxidation-catalytic separation in metered amounts. This results in the oil concentration in the pressurized gas entering the oxidation-catalytic separation means being maintained such that oxidation-catalytic separation can be carried out effectively and under optimum operating conditions without there being an adverse effect on operation by oil concentrations which are suddenly high for an instant.
Patent CA-2507695-A1 (CA)
Title: Arrangement and method for producing a three-dimensional product
Inventor: LARSSON MORGAN
IPC: B33Y10/00
Filed: 2003-12-12
Abstract: An arrangement and method for production of three-dimensional bodies by successive fusing together of selected areas of a powder bed, which parts correspond to successive cross sections of the three-dimensional body, which method comprises the following method steps: application of powder layers to a work table, supplying energy from a radiation gun according to an operating scheme determined for the powder layer to said selected area within the powder layer, fusing together that area of the powder layer selected according to said operating scheme for forming a cross section of said three-dimensional body, a three-dimensional body being formed by successive fusing together of successively formed cross sections from successively applied powder layers.
Patent CA-2508173-A1 (CA)
Inventor: WINFIELD ALAN H
IPC: E06B3/663
Filed: 2002-12-05
Abstract: Cette invention concerne une fenêtre à isolation thermique comprenant une paire de vitres extérieures (14, 16) qui définissent un espace d'air intérieur (12) et qui sont séparées par un élément d'espacement comportant une première et une deuxième surface extérieure opposées et parallèles. Une troisième surface extérieure s'étend entre la première (21) et la deuxième (23) surface extérieure. L'élément d'espacement définit une première rainure d'étanchéité (32) au niveau de l'intersection entre la deuxième (23) et la troisième (19) surface extérieure. Ces rainures d'étanchéité (32) sont remplies d'un élément d'étanchéité étanche au gaz. Une bande de métal (34) chevauche la troisième surface extérieure (19) et comprend des rebords (34A, 34B) qui sont introduits dans les première et deuxième rainures d'étanchéité (32), ce qui isole la troisième surface extérieure (19) de l'élément d'étanchéité.
Patent CA-2508775-A1 (CA)
Inventor: POWELL WILLIAM C
IPC: G06F17/00
Filed: 2004-07-22
Abstract: Les modes de réalisation décrits ont trait à la sécurité des données. Un système à titre d'exemple comprend un premier composant (126) associé à des données sur lesquelles une action peut être exécutée et un deuxième composant (124) configuré pour exécuter cette action sur les données. Le système comprend également un troisième composant (120) configuré pour certifier l'action et pour déterminer, en fonction de l'action, au moins une règle à mettre en oeuvre avant d'autoriser le second composant (124) à accéder aux données.
Patent CA-2510313-A1 (CA)
Title: Saposine c et ses recepteurs cibles pour le traitement de troubles benins et malins
Inventor: KOOCHEKPOUR SHAHRIAR
IPC: C07K14/415
Filed: 2003-12-18
Abstract: La saposine C s'est avérée être le facteur trophique d'une variété de cellules cancéreuses, par exemple de la prostate, des poumons, et du colon. Lesdites cellules exprimant la saposine C répondent à la saposine C par un accroissement de la prolifération, de la migration, et de l'invasion des cellules, de telles activités étant typiques du processus néoplasique et le promouvant. Un conjugué d'un peptide de la région active de la saposine C (TX14A) et d'une toxine (saporine) ayant été obtenu, a montré qu'il réduisait la survie des cellules cancéreuses de la prostate et d'autres cellules s'étant avérées exprimer la saposine, dont les cellules cancéreuses du sein, du colon et des poumons. Ce conjugué ou un composé à action analogue inhibant la croissance cellulaire et agissant via un récepteur de fixation de la saposine C peut servir à réduire la croissance cellulaire et/ou à traiter les troubles de la prolifération du stroma (par exemple l'hyperplasie bénigne de la prostate, l'athérosclérose et les resténoses vasculaires).
Patent CA-2512211-A1 (CA)
Title: Thermal insulated building element
Inventor: MATHE LASZLO
IPC: E04B2/86
Filed: 2003-04-08
Abstract: The invention relates to a thermal insulated building element, which together with connecting elements is suitable for making a building system quickly, which is also suitable for housing and extract fastening of any reinforcement.  The thermal insulated element according to the invention has polystyrene elements with a loadboarding part containing a metal framework between the polystyrene elements said loadbearing part is filled with concrete in-site, furthermore has connecting elements joining the polystyrene elements, which is characterized by that, connecting elements joining the polystyrene elements (1) are plastic connecting elements (19) where fastening holes (8) serving joining the polystyrene elements as well as the nests (20) joining a framework (18) in a space (30) between the polystyrene elements are formed.
Patent CA-2513670-A1 (CA)
Title: Apparatuses, methods and systems relating to findable golf balls
Inventor: GLISSMAN JOHN
IPC: A63B37/00
Filed: 2004-01-15
Abstract: Golf balls and a system for finding golf balls and methods for making golf balls and methods for using such balls. In the case of one exemplary golf ball (102), the ball includes a shell (104) and a core material (100) which is encased in the shell (120) and a tag which is disposed within the core material and which has at least one perforation (109). The tag includes a diode (110)and an antenna which are coupled together. Another exemplary golf ball includes a shell and a core material which is encased within the shell and a tag which is within the core material and which includes an electrical element (106) which is coupled to an antenna; the tag is detectable over a range of at least 20 feet from a handheld device, and the golf ball has high durability and substantially complies with the golf ball specifications of the United States Golf Association.
Patent CA-2513833-A1 (CA)
Title: Use of oxalate deficient aspergillus niger strains for producing a polypeptide
Inventor: LADRIERE JEAN-MARC MAURICE CLA
IPC: C12P21/02
Filed: 2004-02-05
Abstract: The invention relates to oxalate deficient A. niger strains for the production of a given enzyme, wherein the oxalate deficient strain produces at least the same amount of enzyme as the wild type strain it originates from under the same culture conditions. Preferably, the oxalate deficient A. niger strain produces more enzyme than the wild type strain it originates from under the same culture conditions. More preferably, the oxalate deficient A. niger strain is such that when the strain has been transformed with an expression construct comprising a gene coding for an enzyme, said strain produces at least the amount of the enzyme the wild type strain it originates from would produce under the same culture conditions, when the wild type strain has also been transformed with the same expression construct as the oxalate deficient strain. The invention also relates to method for obtaining such oxalate deficient A. niger strain. The present invention further relates to method for producing an enzyme, wherein an oxalate deficient A. niger strain that produces at least the same amount of enzyme as the wild type strain it originates from under the same culture conditions is used.
Patent CA-2514902-A1 (CA)
Title: Manifold system for a medical device
Inventor: MITCHELL JAMES
IPC: A61M5/168
Filed: 2004-02-09
Abstract: A number of devices are illustrated for providing a manifold that can simply and selectively couple a number of different therapeutic and diagnostic elements to a catheter or other medical device. Some examples include devices having sliding actuators, rotary actuators, button actuators, or combinations thereof, for easily changing the valve scheme and fluid pathways within a manifold.
Patent CA-2517974-A1 (CA)
Title: Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1
Inventor: TAYLOR CATHERINE
IPC: C12Q1/68
Filed: 2004-03-05
Abstract: The present invention relates to apoptosis specific eucaryotic initiation factor 5A (eIF-5A), referred to as apoptosis factor 5A1 or simply factor 5A1, apoptosis factor 5A1 nucleic acids and polypeptides and methods for inhibiting or suppressing apoptosis in cells using antisense nucleotides or siRNAs to inhibit expression of factor 5A1. The invention also relates to suppressing or inhibiting expression of pro-inflammatory cytokines by inhibiting expression of apoptosis factor 5A.
Patent CA-2518142-A1 (CA)
Title: Apparatus for entitling remote client devices
Inventor: WASILEWSKI ANTHONY J
IPC: G06F21/00
Filed: 2004-03-05
Abstract: A server in a subscriber television network (100) receives service instances from a headend (102) of the subscriber television network (100). The server is adapted to encrypt according to an encryption scheme and re-transmit service instances to a client-receiver (110). The server reformats the service instance from a first format into a second format the client-receiver can access the service instance.
Patent CA-2519370-A1 (CA)
Title: Wireless telephone antenna diversity system
Inventor: TRAN ALLEN
IPC: H01Q1/24
Filed: 2004-04-02
Abstract: A system and method are provided for diversifying radiated electromagnetic communications in a wireless telephone device. The method comprises: mounting antennas internal to a wireless telephone device chassis; sensing conducted electromagnetic transmission line signals communicated by the antennas; and, selecting between the antennas in response to sensing the transmission line signals. In some aspects, sensing transmission line signals includes sensing transmission line signal power levels. For example, the transmission line signal power levels of transmitted signals reflected by the antennas are sensed. In other aspects, sensing transmission line signals includes sensing the radiated signals received at the antennas and conducted on the transmission line. For example, the power levels of the radiated signals conducted on the transmission lines can be sensed. Alternately, the radiated are received and decoded. Then, the antenna supplying the transmission line signal with the fewest number of decoding errors is selected.
Patent CA-2519724-A1 (CA)
Title: Portable traffic signalling device
Inventor: ROHL BRADLEY S
IPC: G08G1/09
Filed: 2005-09-13
Abstract: A portable traffic signalling device comprises a frame on wheels which supports an enclosed occupant compartment arranged to receive an occupant therein. The compartment is pivotal on the frame between an upright deployed position and a transport position lower in elevation than the deployed position. A traffic indicator is supported on the frame for directing vehicular traffic as controlled by the occupant of the compartment. The device permits a human operator to judge how to direct traffic within a safe environment. The use of a portable compartment with traffic indicators is safer than use of conventional flagpersons to temporarily direct traffic as the occupant of the device is less likely to be subject to fatigue and the like.
Patent CA-2520892-A1 (CA)
Inventor: SEYFRIED CHRISTOPH
IPC: C07D405/12
Filed: 2004-03-08
Abstract: The invention relates to the chromenone indole derivatives of formula (I), wherein R1, R2, R3, R, A and B are defined as in claim 1 and to the pharmaceutically useful prodrugs, derivatives, solvates, stereoisomers and salts thereof. The inventive substances have particular effects on the central nervous system, in particularly they are 5 HT reuptake inhibitors and 5 HTx agonists and/or antagonists. They are characterized by an especially good bioavailability and excellent inhibition of 5 HT reuptake.
Patent CA-2523099-A1 (CA)
Title: Distillation method
Inventor: KAISER BERNHARD
IPC: C12H6/02
Filed: 2004-04-24
Abstract: Disclosed is a method for distilling, e.g. ethanol from a mash or must.  According to said method, a fluid (1) that is fed to a first distillation column (stripper, 13) and a distillate (4) of the first distillation column (13) are delivered to a second distillation column (rectification column, 14).  The fed fluid (1) and/or a distillate (7) of the second distillation column (14) is/are purified in a first and/or last step of the inventive method by means of a membrane separation process.
Patent CA-2525408-A1 (CA)
Title: Microbicidal air filter
Inventor: BOLDUC NORMAND
IPC: A61L9/00
Filed: 2003-06-06
Abstract: Microbicidal air filter (10) for use with an air passageway, which comprises an immobilization network (12) having substantially impregnated therein an amount of at least one antimicrobial substance sufficient to substantially immobilize, retain and kill microbes suspended in a volume of air moving through the air passageway. The immobilization network (12) is substantially permeable to air. A microbicidal facemask (24) and a microbicidal air filter (10) used in an air circulation system (40) using the immobilization network (12) are disclosed.
Patent CA-2527615-A1 (CA)
Title: Gas phase polymerization and method of controlling same
Inventor: LAMBERT GLENN A
IPC: C08F210/16
Filed: 2004-05-26
Abstract: A process for controlling a continuous gas phase exothermic process in a reactor comprising: (i) effecting a gas phase exothermic reaction under a set of operating conditions in the presence of a cooling agent, the cooling agent having a pre-selected concentration and feed rate of an induced cooling agent;  (ii) determining a maximum production rate (I) without regard to limitations due to the cooling agent under the operating conditions; (iii) determining a maximum production rate (II) with regard to limitations due to the cooling agent under the operating conditions; (iv) calculating an optimal concentration of the induced cooling agent such that the difference between (I) and (II) is minimized; and (v) adjusting the feed rate of the induced cooling agent to achieve the concentration value calculated in (iv).
Patent CA-2529254-A1 (CA)
Title: Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions
Inventor: HARSIN LASZLO GABOR
IPC: A61P25/28
Filed: 2004-06-22
Abstract: The invention relates to the use of compounds of the general Formula (I), wherein R3 stands for hydrogen or hydroxy; R1 stands for hydrogen or alkyl;  and R2 stands for alkyl) and pharmaceutically acceptable acid addition salts for the preparation of pharmaceutical compositions having neuroprotective effect.
Patent CA-2533489-A1 (CA)
Title: Expansion tank with double diaphragm
Inventor: LOMBARI ROBERT
IPC: F24D3/10
Filed: 2004-07-19
Abstract: A double-diaphragm bladder. The bladder comprises a non-flexible diaphragm having a peripheral edge and a flexible diaphragm having a peripheral edge.  The non-~flexible diaphragm has an aperture adapted and constructed to be connected to a liquid port, and the peripheral edges of the non-flexible diaphragm and the flexible diaphragm are sealed together. The bladder is suitable for use in an expansion tank.
Patent CA-2537036-A1 (CA)
Title: Handheld electronic device, cursor positioning sub-system and method employing cursor scaling control
Inventor: MOOSAVI VAHID
IPC: G06F3/038
Filed: 2006-02-21
Abstract: A track ball cursor positioning sub-system is employed by a handheld electronic device including an operating system and a plurality of applications having a plurality of predetermined scaling values. The cursor positioning sub-system includes a track ball cursor positioning device adapted to output a plurality of device pulses, and a track ball cursor resolution controller adapted to repetitively input the device pulses and to responsively output to the operating system a plurality of cursor movement events. The cursor resolution controller is further adapted to be controlled by the operating system or by the applications to learn which one of the applications is active and to automatically scale a number of the cursor movement events for a corresponding number of the device pulses based upon a corresponding one of the predetermined scaling values of the active one of the applications.
Patent CA-2537429-A1 (CA)
Title: Method and device for detecting feline immunodeficiency virus
Inventor: TONELLI QUENTIN J
IPC: G01N33/53
Filed: 2004-09-10
Abstract: A method and device for determining a feline immunodeficiency virus infection or vaccination in an animal. The method includes contacting a biological sample from a felid with various FIV polypeptides and determining the binding of antibodies in the sample to the polypeptides. The determination of whether an animal is infected with FIV or has been vaccinated against FIV can be determined by measuring the animal~s immune response to an FIV env polypeptide. A device for detecting FIV antibodies is provided.
Patent CA-2539440-A1 (CA)
Inventor: COLEMAN THOMAS
IPC: A61K38/19
Filed: 2004-09-29
Abstract: A method of treating, preventing, delaying the onset, and/or reducing the effects of proinflammatory cytokines in conditions including, but not limited to, sepsis, adhesion formation, wounds, organ failure, chronic disease, general inflammatory conditions resulting from infection, scarring resulting from injury and incisions, and combinations thereof.
Patent CA-2539601-A1 (CA)
Inventor: VULETIC BOGDAN
IPC: C21B3/08
Filed: 2004-09-17
Abstract: In a process for granulating slag, from a blast furnace or a smelting reduction plant, in which a granule/water mixture formed during the granulation is fed to a granulation tank and then to a dewatering installation, in which the slag granules are dewatered. H2S-containing vapors and gases formed during the granulation are at least partially condensed by injection of water in a condensation space which is flow-connected to the granulation tank. H2S-containing residual gases are discharged from the compensation space below the water injection point, H2S is burnt.